Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab

Merkel cell carcinoma has historically had dismal prognosis with limited cytotoxic chemotherapy options that provide durable control of metastatic disease. The advent of anti-programmed death protein (anti-PD1)/anti-programmed death-ligand 1 (anti-PD-L1) directed immunotherapy has shown initial prom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Bloom, Brooke C., Augustyn, Alexander, Pezzi, Todd A., Menon, Hari, Mayo, Lauren L., Shah, Shalin J., Schwartz, David L., Chmura, Steven J., Johnson, Faye M., Welsh, James W., Chun, Stephen G.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6459944/
https://ncbi.nlm.nih.gov/pubmed/31024834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados